Every earnings call announcement on NSE and BSE that our alert engine sent, newest first. Each one has its own page with the summary, the key figures and the original filing.
Jash Engineering reported Q1 FY27 revenue of ₹156 crore, up 17% YoY. PAT turned positive at ₹5 crore. Management remains bullish on achieving annual targets despite geopolitical shipping delays in the Gulf and Singapore.
BMW Industries reports strong Q1 FY27 revenue growth, though margins were temporarily squeezed by geopolitical fuel price spikes. Management is betting heavily on the new Bokaro facility to drive massive multi-year scale.
Ion Exchange reported Q1 FY27 consolidated revenue of INR 701 Cr (+20% YoY) but a sharp decline in EBITDA to INR 32 Cr (-49%) and PAT to INR 3 Cr (-90%).
Max Healthcare delivered strong Q1 FY27 results with Net Revenue growing 15% YoY to ₹2,835 Cr and Operating EBITDA rising 15% to ₹704 Cr, driven by improved ARPOB and occupancy.
Chandan Healthcare reported strong Q1 FY27 results with 19.62% YoY revenue growth and 42.27% EBITDA growth, driven by expansion into 15 states and diversified B2C, B2B, and B2G segments.
Triveni Turbine reported Q1 FY27 revenue growth of 19.2% YoY to ₹4.43 billion. Profitability was softer due to a higher domestic revenue mix and execution of strategic low-margin projects like the NTPC CO2 storage pilot.
Modi Naturals Q1FY27 consolidated revenue remained stable at ₹155.6 Cr, while EBITDA grew 25.3% to ₹22.2 Cr. Management is pivoting towards high-margin Ethanol and Branded Consumer segments.
Venus Pipes delivered record Q1 FY27 performance with revenue of ₹320.5 Cr and EBITDA of ₹51.5 Cr, driven by capacity expansion and forward integration into fittings and spooling.
Vasa Denticity (Dentalkart) reported a 'repair quarter' focusing on in-house brands and operational automation to improve gross margins and cost-to-serve for Q1 FY27.
Max Estates delivered a strong Q1 FY27, capitalizing on the NCR residential boom while aggressively pivoting toward a self-funded model through massive collections and pre-sales growth.
Olectra delivered 66% YoY revenue growth in Q1 FY27, yet EBITDA margins faced pressure from raw material inflation and geopolitical shipping disruptions.
UFLEX delivered a strong Q1 FY27 with revenue up 38% YoY and EBITDA margins expanding 480 bps. Growth was heavily driven by overseas operations and price realizations following Red Sea crisis-induced supply disruptions.
Xtglobal reported stable Q1 FY27 results, showing 8% YoY standalone revenue growth. Management's narrative focuses on international expansion and shifting work offshore to protect margins despite a cautious global IT spending environment.
Suraj Estate reports 10% revenue growth in Q1FY27, but rising debt levels and slowing residential sales volume signal growing execution and leverage risks.
EIH Ltd reported 15% revenue growth in Q1FY27, driven by strong domestic demand and flight catering. Strategy focuses on premium positioning and a 30-property expansion pipeline by 2031.
Bata India reported Q1FY27 revenue of ₹979 crores, up 4% YoY, with underlying PBT growing 22%. Strategy focuses on premiumization, EBO expansion to 3,000 stores, and product funnel reimagination.
Camlin Fine Sciences reported Q1 FY27 revenue of INR 5,199 million, up 28% YoY, though EBITDA margins were pressured to 4% by high raw material and freight costs.
Zuari reports a 22% revenue jump driven by sugar volumes, but higher input costs and sugar cane prices (SAP) squeezed standalone EBITDA margins to 5.2%.
Gufic reports strong Q1 FY27 growth, driven by Indore plant ramp-up and expansion into high-margin complex injectables like GLP-1 (Semaglutide) and Botulinum Toxin.
Indag Rubber Q1 FY27 revenue grew 26% YoY to ₹60.45 Cr with PAT nearly tripling to ₹5.07 Cr. Management is focusing on product mix and channel expansion while navigating high raw material costs.
Revenue grew 10% YoY, but margins crashed due to one-off costs. Management is aggressively shifting high-cost UK/Europe roles to India to restore profitability.
Allcargo Global posted a sequential recovery with Q1 revenue of ₹3,522 Cr, despite geopolitical headwinds in the Middle East impacting FCL volumes. Management is pivoting toward AI-driven cost optimization to offset macro-stagnation.
GIC Re shows margin improvement via portfolio pruning, yet remains under pressure from intense domestic competition and flat investment income. Management is pivoting toward retail health while reducing underperforming international motor and property exposures.
Paramount shows a strong recovery driven by US export normalization and domestic power infrastructure demand, successfully returning to FY25 margin levels.